Trial Profile
Qsymia as an Adjunct to Surgical Therapy in the Superobese
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Apr 2023
Price :
$35
*
At a glance
- Drugs Phentermine/topiramate (Primary)
- Indications Obesity
- Focus Therapeutic Use
- 01 Jun 2023 secondary analysis Results assessing the impact of PT + SG on blood pressure (BP), heart rate, and antihypertensive usage, published in the Journal of Surgical Research
- 20 Aug 2019 According to a VIVUS Media Release, results from this study were published in the Surgery for Obesity and Related Diseases.
- 20 Aug 2019 Results presented in the VIVUS Media Release.